Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.345 USD | +2.71% | -1.71% | +128.01% |
May. 13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
May. 08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart calendar Mind Medicine (MindMed) Inc.
Upcoming events on Mind Medicine (MindMed) Inc.
Past events on Mind Medicine (MindMed) Inc.
2024-05-19 | H.C. Wainwright BioConnect Investor Conference |
2024-05-15 11:00 am | RBC Capital Markets Global Healthcare Conference - Fireside Chat |
2024-05-08 04:30 pm | Q1 2024 Earnings Call |
2024-05-08 04:01 pm | Q1 2024 Earnings Release |
2024-05-07 | International Society for Pharmacoeconomics and Outcomes Research Conference - Work Productivity Los |
2024-05-05 | International Society for Pharmacoeconomics and Outcomes Research Conference - Health-related Qualit |
2024-05-05 | International Society for Pharmacoeconomics and Outcomes Research Conference - Health Care Resource |
2024-05-03 | American Psychiatric Association Congress - Dan Karlin, MD |
2024-05-03 | American Psychiatric Association Congress - Phong Duong, PharmD |
2024-05-03 | American Psychiatric Association Congress - Quantifying the Burden of Undiagnosed Generalized |
2024-04-12 05:00 pm | Anxiety & Depression Association of America Conference |
2024-04-09 03:30 am | European Psychiatric Association Congress |
2024-03-10 | Leerink Partners Global Biopharma Conference |
2024-03-07 08:00 am | MM120 Phase 2b Trial Results Update Call |
2024-02-28 08:00 am | Q4 2023 Earnings Call |
2024-02-28 07:05 am | Q4 2023 Earnings Release |
2024-02-13 10:00 am | Oppenheimer Healthcare Life Sciences Conference |
2022-06-10 12:15 pm | Jefferies Healthcare Conference |
2022-06-01 10:00 am | Annual General Meeting |
2022-05-19 11:00 am | Investor Meeting - Key Opinion Leader |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -31,9 -18,5 -72.36% | -91,2 -87,7 -4.03% | -63,2 -63,8 1.02% | -90,7 -90,9 0.22% | -88,3 |
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -93,9 -95,4 1.66% | -66,3 -69,3 4.29% | -93,9 -93,7 -0.19% | -94,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,3 -25,3 -39.64% | -94,2 -95,1 0.91% | -56,8 -68,9 17.57% | -95,7 -93,3 -2.56% | -123 |
Net income Million USD | Released Forecast Spread | -5,47 | -35,3 -25,3 -39.64% | -93,0 -95,1 2.12% | -56,8 -69,0 17.65% | -95,7 -93,3 -2.59% | -123 |
EPS USD | Released Forecast Spread | -0,75 | -1,50 -1,50 0% | -3,45 -3,50 1.43% | -1,84 -2,30 19.85% | -2,44 -2,29 -6.55% | -1,83 |
Announcement Date | 30/03/20 | 30/03/21 | 28/03/22 | 09/03/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -17,7 -18,7 5.21% | -16,1 -18,6 13.32% | -16,2 -15,0 -7.95% | -13,1 -13,7 4.31% | -20,1 -15,6 -28.66% | -28,4 -21,5 -32.07% | -20,8 -23,3 10.62% | -21,4 -21,6 0.86% | -20,1 | -20,6 | -21,9 | -24,1 | ||
EBIT Million USD | Released Forecast Spread | -18,5 -21,9 15.31% | -16,9 -19,7 13.79% | -17,0 -17,3 2.06% | -13,9 -16,9 17.63% | -20,9 -16,0 -30.45% | -29,2 -21,3 -37.28% | -21,6 -26,5 18.55% | -22,2 -22,0 -0.88% | -22,2 -22,1 -0.5% | -22,8 | -23,9 | -25,8 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,5 -21,9 15.56% | -17,0 -19,7 13.72% | -16,5 -17,3 4.94% | -4,90 -16,9 70.9% | -24,8 -15,9 -56.46% | -29,1 -20,9 -39.11% | -17,9 -26,4 32.04% | -23,9 -21,5 -11.06% | -54,4 -21,4 -154.03% | -21,7 | -22,5 | -24,1 | ||
Net income Million USD | Released Forecast Spread | -18,5 -21,9 15.56% | -17,0 -19,7 13.72% | -16,5 -17,3 4.94% | -4,90 -16,9 70.9% | -24,8 -15,9 -56.46% | -29,1 -20,9 -39.11% | -17,9 -26,4 32.04% | -23,9 -21,5 -11.06% | -54,4 -25,8 -111.16% | -21,3 | -22,0 | -25,0 | ||
EPS USD | Released Forecast Spread | -0,60 -0,70 14.29% | -0,60 -0,75 20% | -0,56 -0,60 5.88% | -0,02 -0,50 96.03% | -0,65 -0,43 -50.58% | -0,76 -0,55 -39.45% | -0,45 -0,68 34.02% | -0,59 -0,48 -23.78% | -1,14 -0,54 -109.82% | -0,30 | -0,31 | -0,35 | -0,36 | -0,36 |
Announcement Date | 16/05/22 | 11/08/22 | 10/11/22 | 09/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | 08/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Mind Medicine (MindMed) Inc.
Today | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
Today | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MNMD Stock
- Calendar Mind Medicine (MindMed) Inc.